Kate Beattie
- Commercial Law Intellectual Property
- Public Law
Kate has a background in pharmacology and regularly acts for pharmaceutical and healthcare companies. She also advises on trade practices and commercial disputes, particularly those involving scientific expert evidence.
She holds a Bachelor of Science majoring in pharmacology and toxicology, a Bachelor of Laws (First Class Honours) from Monash University and a Master of Law (First Class Honours) from the University of Cambridge.
Before coming to Bar, Kate was a senior associate in the intellectual property department at Allens Arthur Robinson. She also practised at Freshfields Bruckhaus Deringer, London. Kate is an author of the text book, "Australian Patent Law" (2004). She has also been a sessional lecturer in contract law in the LLM (Juris Doctor) Program, Monash University.
Kate has been repeatedly recommended in Chambers and Partners. In 2023, she was described as having “significant experience in patent cases, particularly in the pharmaceutical field. Her work is of very high quality, and she is a pleasure to work with.”
Liability limited by a scheme approved under Professional Standards legislation.
Contact
- P+61 3 9225 6729
- M0413 610 315
- E[email protected]
- Connect on Linkedin
Emmerson Chambers
Room 8 Level 18
200 Queen Street
Melbourne VIC 3000
Jane King
+61 3 9225 8558
0414 251 921
Expertise
- Competition
- Consumer Law
- Contractual Disputes
- Appellate
- Copyright & Designs
- Patents
- Trade Marks
- Privacy
Qualifications
Master of Laws (First Class Hons)(Cambridge)
Bachelor of Laws (First Class Hons)(Monash)
Bachelor of Science (Pharmacology and Toxicology)
Victoria
State and Territory Courts and Tribunals
Federal Court of Australia
High Court of Australia
Recent Cases
Janssen Sciences Ireland Unlimited Company v Juno Pharmaceutical NSD 698 of 2020
CSIRO v BASF Plant Science GmbH [2020] FCA 328
ESCO Australia Holding P/L v CQMS and Anor VID 63 of 2019
Interpharma Pty Ltd v Hospira, Inc (No. 5) [2019] FCA 960
GlaxoSmithKline Consumer Healthcare Investments (Ireland) (No 2) Limited v Generic Partners Pty Ltd [2018] FCAFC 71
Daiwa Can Company v Barokes Pty Ltd [2016] VSC 296
Paul Laurence Mizzi v Daryl Morellini [2015] APO 24 (patent opposition)
Re Gunns Plantations Ltd [2014] VSC 369 (insolvency)
Ranbaxy Laboratories Ltd v AstraZeneca AB (2013) 101 IPR 11 (pharmaceutical patent litigation)
Vehicles Monitoring Systems Pty Ltd v Sarb Management Group Pty Ltd (2013) 101 IPR 496 (patent litigation)
Spotless v Qantas Airways (2012) No VID 1183 of 2011 (trade mark and trade practices litigation)
Albany Molecular Research Inc v Alphapharm Pty Ltd (2011) 90 IPR 457 (pharmaceutical patent litigation)
Primary Health Care Limited v The Commissioner of Taxation of the Commonwealth of Australia (2010) 186 FCR 301 (tax, copyright)
Vawdrey Australia Pty Ltd v Krueger Transport Equipment Pty Ltd (2009) 83 IPR 1 (copyright, confidential information)
GlaxoSmithKline Australia Pty ltd v Jarrod Ritchie and TPI Enterprises Pty Ltd (2008) 77 IPR 306 (confidential information)
Ranbaxy Australia Pty Ltd v Warner-Lambert Company LLC (2008) 77 IPR 449 (pharmaceutical patent litigation)